From: Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy
Type of stimulation | Â | Protocol | in vivo | in vitro | Comments | References |
---|---|---|---|---|---|---|
Electrical nerve stimulation: C-fibres | HFS | 100 Hz for 1 s, repeated 2-20 times at 10-20 s intervals | • | • |  | [3, 4, 6, 17, 40, 65, 70, 90, 92, 101, 102, 108, 110, 113, 133, 134, 143, 144, 268, 269] (superficial dorsal horn), [14, 29, 114, 270] (deep dorsal horn) |
 | LFS | 2 Hz, 120 s | • | • |  | |
 |  | 1-2 Hz, 40-100 s paired with postsynaptic depolarisation |  | • |  | |
 | IFS | 10 Hz for 1 s, repeated 12 times at 10 s |  | • |  | [83] |
 |  | 20 Hz for 5 s, repeated 4 times at 10 s intervals | • |  |  | [3] |
Electrical nerve stimulation: Aδ-fibres | HFS | 100 Hz for 1 s, repeated 90 times at 10 s intervals | • |  | LTP only in spinalised rats | [36] |
Natural noxious stimulation |  | Noxious heat, pinching (hindpaw) | • |  | LTP only in spinalised rats | [13] |
 |  | Formalin, capsaicin injection (hindpaw) | • |  |  | |
 |  | Sciatic nerve transsection or crush | • |  |  | [11] |
 |  | Sural nerve crush | • |  | LTP only in spinalised rats | [13] |
Pharmacological stimulation |  | NMDA, substance P, neurokinin A | • |  | LTP only in spinalised rats | [272] |
 |  | ATP | • |  |  | [122] |
 |  | BDNF, SKF 38393 (Dopamine receptor D1/D5 agonist), 8-Br-cAMP (PKA activator) | • |  | Late, protein-synthesis- dependent phase of LTP | |
 |  | Abrupt withdrawal of remifentanil or DAMGO | • | • | No LTP upon tapered withdrawal | |
 |  | TNF-α | • |  | LTP only in neuropathic animals | [111] |